CME Group (NASDAQ:CME) Shares Down 11.9% After Analyst Downgrade

CME Group Inc (NASDAQ:CME)’s share price was down 11.9% during mid-day trading on Monday after Bank of America lowered their price target on the stock from $216.00 to $168.00. Bank of America currently has a neutral rating on the stock. CME Group traded as low as $136.72 and last traded at $139.54, approximately 3,845,221 shares changed hands during mid-day trading. An increase of 68% from the average daily volume of 2,289,641 shares. The stock had previously closed at $158.41.

A number of other equities research analysts have also recently commented on the company. JPMorgan Chase & Co. decreased their price target on CME Group from $183.00 to $173.00 and set an “underweight” rating on the stock in a report on Friday, December 6th. Deutsche Bank dropped their price objective on CME Group from $260.00 to $243.00 and set a “buy” rating for the company in a research note on Wednesday, March 18th. Oppenheimer assumed coverage on CME Group in a research report on Wednesday, February 12th. They set a “buy” rating and a $234.00 target price for the company. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 17th. Finally, Sanford C. Bernstein downgraded CME Group from an “outperform” rating to a “market perform” rating in a research note on Friday, January 10th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $208.27.

In related news, COO Julie Holzrichter sold 3,061 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $203.37, for a total value of $622,515.57. Following the sale, the chief operating officer now owns 37,284 shares in the company, valued at $7,582,447.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Julie Winkler sold 5,620 shares of the business’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $210.97, for a total transaction of $1,185,651.40. Following the completion of the sale, the insider now owns 25,114 shares in the company, valued at approximately $5,298,300.58. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,681 shares of company stock valued at $2,009,327. Company insiders own 1.20% of the company’s stock.

Large investors have recently modified their holdings of the business. Solstein Capital LLC purchased a new stake in CME Group during the 4th quarter valued at $26,000. Evoke Wealth LLC bought a new position in CME Group during the third quarter valued at $27,000. CFM Wealth Partners LLC purchased a new stake in shares of CME Group in the fourth quarter valued at $30,000. Virtus ETF Advisers LLC purchased a new stake in shares of CME Group in the fourth quarter valued at $32,000. Finally, Thor Advisors LLC purchased a new stake in shares of CME Group in the third quarter valued at $34,000. 85.27% of the stock is owned by institutional investors and hedge funds.

The company’s fifty day moving average price is $199.26 and its 200-day moving average price is $205.23. The stock has a market cap of $56.77 billion, a P/E ratio of 25.76, a price-to-earnings-growth ratio of 2.59 and a beta of 0.19. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $1.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.54 by ($0.02). The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.16 billion. CME Group had a return on equity of 9.22% and a net margin of 43.48%. The business’s revenue for the quarter was down 7.9% compared to the same quarter last year. During the same period last year, the company earned $1.77 earnings per share. Analysts anticipate that CME Group Inc will post 7.58 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be paid a dividend of $0.85 per share. This is a boost from CME Group’s previous quarterly dividend of $0.75. The ex-dividend date is Monday, March 9th. This represents a $3.40 dividend on an annualized basis and a dividend yield of 2.23%. CME Group’s dividend payout ratio is currently 50.00%.

About CME Group (NASDAQ:CME)

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

error: Content is protected !!